SILDENAFIL
NDC 69097-952, SILDENAFIL, tablet, from CIPLA USA INC.,.
- Product NDC
- 69097-952
- Status
- Listed
- Labeler
- CIPLA USA INC.,
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207178
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-952 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SILDENAFIL CITRATE50 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-952-02 | 69097095202 | 30 TABLET in 1 BOTTLE (69097-952-02) |
| 69097-952-07 | 69097095207 | 100 TABLET in 1 BOTTLE (69097-952-07) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/15372a7c-2935-48dc-a55a-8966719b50be
Use it
Look up 69097-952 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-952 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-952. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.